1887

Abstract

Purpose. To examine whether the epidemiology of bacteraemia caused by methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) differed in children aged <1 year and in comparison to older age groups.

Methodology. English mandatory MRSA and MSSA surveillance data from 2006 and 2011, respectively, were collected. Epidemiological information was descriptively analysed in relation to methicillin susceptibility and patient age. Ninety-five percent confidence intervals (CIs) are reported.

Results/Key findings. The average incidence rate of MSSA and MRSA bacteraemia in <1-year-olds was 60.2 and 4.8 episodes per 100 000 population per year, respectively. Of the cases of MSSA bacteraemia in children aged <1 year, 47.5 % (95 % CI: 45.1–50.0; n=760/1 599) were in neonates. With increasing age up to one year, more MSSA bacteraemias were detected ≥7 days after admission, ranging from 0 % (95 % CI: 0–2.5 %) in 0–2-day-olds to 68.4 % (95 % CI: 64.0–72.5 %; 333/487) in 8–28-day-olds and 50.5 % (95 % CI: 47.1–54.0 %; 423/837) in 29 day–1-year-olds, a higher proportion than in older children but similar to MRSA bacteraemia. Amongst <1-year-olds with MSSA bacteraemia, the underlying source was most commonly recorded as intravascular devices [34.4 % (95 %, CI: 30.5–38.6 %); n=190/552] whilst in older age groups this declined. A similar trend was observed for MRSA bacteraemia.

Conclusions. Our analysis indicates that S. aureus bacteraemia in <1-year-olds is primarily healthcare-associated, unlike MSSA bacteraemia in older age groups. Paediatric-specific interventions targeted at the healthcare setting, such as neonatal unit-specific care bundles and paediatric device-specific strategies, are required.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000489
2017-06-09
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/6/737.html?itemId=/content/journal/jmm/10.1099/jmm.0.000489&mimeType=html&fmt=ahah

References

  1. Public Health England 2013; Voluntary reporting of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland. GOV UK Website 2014www.gov.uk/government/publications/staphylococcus-aureus-annual-trends-in-voluntary-surveillance [accessed 11 September 2015]
  2. Johnson AP, Sharland M, Goodall CM, Blackburn R, Kearns AM et al. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 2010;95:781–785 [CrossRef][PubMed]
    [Google Scholar]
  3. Frederiksen MS, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR et al. Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J 2007;26:398–405 [CrossRef][PubMed]
    [Google Scholar]
  4. Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000–2006. Pediatr Infect Dis J 2009;28:114–117 [CrossRef][PubMed]
    [Google Scholar]
  5. Lyytikäinen O, Ruotsalainen E, Järvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001. Eur J Clin Microbiol Infect Dis 2005;24:399–404 [CrossRef][PubMed]
    [Google Scholar]
  6. Vanderkooi OG, Gregson DB, Kellner JD, Laupland KB. Staphylococcus aureus bloodstream infections in children: a population-based assessment. Paediatr Child Health 2011;16:276–280 [CrossRef][PubMed]
    [Google Scholar]
  7. Adedeji A, Gray JW. MRSA at an English children's hospital from 1998 to 2003. Arch Dis Child 2005;90:720–723 [CrossRef][PubMed]
    [Google Scholar]
  8. Gray J, O'Donoghue B. Bacteraemia with meticillin-susceptible Staphylococcus aureus in an English children's hospital. J Hosp Infect 2011;78:158–159 [CrossRef][PubMed]
    [Google Scholar]
  9. Hakim H, Mylotte JM, Faden H. Morbidity and mortality of Staphylococcal bacteremia in children. Am J Infect Control 2007;35:102–105 [CrossRef][PubMed]
    [Google Scholar]
  10. Department of Health . Extension of mandatory surveillance to Meticillin Sensitive Staphylococcus aureus. (MSSA) and updated Healthcare Assocated Infections clinical guidance ("HCAI Compendium"). 2011; Gateway referece: 15353. [6-1-2011]
  11. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012;67:802–809 [CrossRef][PubMed]
    [Google Scholar]
  12. Health and Social Care Information Centre 2017; Hospital Estates and Facilities Statistics 2013/14. HSCIC Website 2017http://hefs.hscic.gov.uk/DataFiles.asp [accessed 03 March 2017]
  13. Public Health England 2016; Mandatory enhanced MRSA, MSSA and Escherichia coli bacteraemia, and Clostridium difficile infection surveillance. Protocol version 4.0. https://hcaidcs.phe.org.uk/ContentManagement/LinksAndAnnouncements/HCAIDCS_Mandatory_Surveillance_Protocol_v4.0.pdf [accessed 03 March 2017]
  14. Office for National Statistics 2012; Mid-2011 population estimates: England; estmiated resident population by single year of age and sex; based on the results of the 2011 census. http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-262039 [accessed 21 November 2016]
  15. StataCorp 2013; Stata Statistical Software: Release 13. College Station, TX. StataCorp LP:
  16. Achermann Y, Seidl K, Kuster SP, Leimer N, Durisch N et al. Epidemiology of Methicillin-Susceptible Staphylococcus aureus in a Neonatology Ward. Infect Control Hosp Epidemiol 2015;36:1305–1312 [CrossRef]
    [Google Scholar]
  17. Scott MA, Panesar P, Grosso AM, Urquhart R, Jeanes A et al. Rapid molecular screening for meticillin-sensitive Staphylococcus aureus (MSSA) carriage: an economic evaluation. J Infect Prev 2011;12:119–125 [CrossRef]
    [Google Scholar]
  18. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L et al. Born Too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013;10:S2 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000489
Loading
/content/journal/jmm/10.1099/jmm.0.000489
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error